Biomarker and Companion Diagnostics Event-20th - 21st June 2024 -Boston, USA
MarketsandMarkets brings to you the Biomarker and Companion Diagnostics Conference scheduled to be held on 20th - 21st June 2024 in Boston, USA. This event will have an introduction to turning biomarkers into companion diagnostics.\n\nEnquire Now @ https:\/\/events.marketsandmarkets.com\/2nd-annual-
4 views • 5 slides
Technological Advancements in Molecular Diagnostics is Driving the Growth of this Market
North America Molecular Diagnostics Market by Product (Reagents & Kits, Systems, Software), Test Type (Lab, PoC), Technology (PCR, ISH, INAAT, Sequencing, Microarray), Application (Infectious Diseases, Oncology, Neurological), End User
0 views • 3 slides
Increasing Focus on Companion Diagnostics Creates an Opportunity for the Europe
Europe Molecular Diagnostics Market by Product (Reagents & Kits, Systems, Software), Test Type (Lab, PoC), Technology (PCR, INAAT, Sequencing, Microarray), Application (Infectious Diseases, Oncology), End User (Hospital, Diagnostic Lab)
0 views • 3 slides
Asia-Pacific Molecular Diagnostics Market
Asia-Pacific Molecular Diagnostics Market\nAsia-Pacific Molecular Diagnostics Market by Product & Service (Kits, Instruments) Test Type (Lab, PoC) Technology (PCR, ISH, Sequencing, INAAT, Microarray) Application (Infectious Diseases, Oncology) End User (Hospitals, Diagnostic Lab)
0 views • 3 slides
Latin America Molecular Diagnostics Market
Latin America Molecular Diagnostics Market by Offering (Reagents, Kits, Systems, Software, Services), Test Type (Lab, PoC), Technology (PCR, ISH, INAAT, Sequencing, Microarray), Application (HIV, Influenza, HPV, Oncology), End User
0 views • 3 slides
South East Asia Molecular Diagnostics Market
Meticulous Research\u00ae\u2014a leading market research company, published a research report titled, \u2018South East Asia Molecular Diagnostics Market by Offering (Reagents, Kits, Systems, Software), Test Type (Lab, PoC), Technology (PCR, ISH, INAAT, Sequencing, Microarray), Application (HIV, Infl
0 views • 3 slides
Medical Device & Diagnostics Post-Market Surveillance and Vigilance Conference
Introduction:\nIn the heart of Dusseldorf, Germany, the MarketsandMarkets European Medical Device & Diagnostics Post-Market Surveillance and Vigilance Conference is set to unfold on the 14th-15th October 2024. \n\nEnquire Now @ https:\/\/events.marketsandmarkets.com\/european-medical-devices-and-dia
2 views • 5 slides
Enhancing Diagnostics Programme for Improved Healthcare in Cheshire and Merseyside
Diagnostics are crucial for prevention, monitoring, and improving patient outcomes. The programme in Cheshire and Merseyside aims to provide equitable, efficient, and innovative diagnostic services to enhance the overall health and well-being of the community. It covers a wide range of tests and foc
0 views • 17 slides
Biomarker and Companion Diagnostics Conference -USA (20th - 21st June 2024)
MarketsandMarkets brings to you the Biomarker and Companion Diagnostics Conference scheduled to be held on 20th - 21st June 2024 in Boston, USA. This event will have an introduction to turning biomarkers into companion diagnostics.\n\nBecome a Speaker @ \/\/events.marketsandmarkets.com\/2nd-annual-b
1 views • 6 slides
Molecular Diagnostics Market_Blog
The molecular diagnostics market comprises advanced products and technologies used by medical professionals for patient management, from diagnosis to treatment, primarily focusing on areas such as infectious disease and cancer.
0 views • 3 slides
Meticulous Research® Forecasts Middle East & Africa Molecular Diagnostics Market to Exceed $1.16 Billion
Middle East & Africa Molecular Diagnostics Market by Offering (Reagents, Kits, Systems, Software) Test Type (Lab, PoC) Technology (PCR, ISH, INAAT, Sequencing, Microarray) Application (Influenza, HPV, Oncology, Gene Testing) End User
0 views • 2 slides
Europe Molecular Diagnostics Market Primed to Surpass $13.25 Billion by 2030
Europe Molecular Diagnostics Market by Product (Reagents & Kits, Systems, Software), Test Type (Lab, PoC), Technology (PCR, INAAT, Sequencing, Microarray), Application (Infectious Diseases, Oncology), End User (Hospital, Diagnostic Lab)
1 views • 2 slides
North America Molecular Diagnostics Market Projected to Reach $18.13 Billion by 2030
North America Molecular Diagnostics Market by Product (Reagents & Kits, Systems, Software), Test Type (Lab, PoC), Technology (PCR, ISH, INAAT, Sequencing, Microarray), Application (Infectious Diseases, Oncology, Neurological), End User
1 views • 2 slides
Advanced Instrumentation and Diagnostics for Superconducting Magnets at CERN
Explore the crucial needs for instrumentation and diagnostics at CERN, focusing on superconducting magnets. Topics include voltage and strain measurements, vibration analysis, temperature sensing, quench detection, and magnet form factor considerations. The importance of advanced diagnostics and com
1 views • 23 slides
Latin America Molecular Diagnostics Market Projected to Reach $2.50 Billion by 2031
Latin America Molecular Diagnostics Market by Offering (Reagents, Kits, Systems, Software, Services), Test Type (Lab, PoC), Technology (PCR, ISH, INAAT, Sequencing, Microarray), Application (HIV, Influenza, HPV, Oncology), End User
0 views • 2 slides
South East Asia Molecular Diagnostics Market - Global Opportunity Analysis and Industry Forecast (2024-2031)
Meticulous Research\u00ae\u2014a leading market research company, published a research report titled, \u2018South East Asia Molecular Diagnostics Market by Offering (Reagents, Kits, Systems, Software), Test Type (Lab, PoC), Technology (PCR, ISH, INAAT, Sequencing, Microarray), Application (HIV, Infl
3 views • 4 slides
Europe Cancer Diagnostics Market: Emerging Trends in Liquid Biopsy and Next-Gene
The Europe Cancer Diagnostics Market is projected to reach $12.21 billion by 2031, at a CAGR of 5.6% during the forecast period 2024\u20132031. The Europe cancer diagnostics market is driven by the rising prevalence of cancer, supporting initiatives for early cancer diagnosis, increasing investments
3 views • 4 slides
Latin America Molecular Diagnostics Market - Opportunity Analysis
Latin America Molecular Diagnostics Market by Offering (Reagents, Kits, Systems, Software, Services), Test Type (Lab, PoC), Technology (PCR, ISH, INAAT, Sequencing, Microarray), Application (HIV, Influenza, HPV, Oncology), End User - Forecast to 2031\n
3 views • 3 slides
Africa Molecular Diagnostics Market
Middle East & Africa Molecular Diagnostics Market by Offering (Reagents, Kits, Systems, Software) Test Type (Lab, PoC) Technology (PCR, ISH, INAAT, Sequencing, Microarray) Application (Influenza, HPV, Oncology, Gene Testing) End User - Forecast to 2031
1 views • 5 slides
Molecular Diagnostics Market Projected to Reach $46.69 Billion by 2030
Molecular Diagnostics Market by Product (Reagent & Kits, Systems, Software), Test Type (Lab, PoC), Technology (PCR, ISH, INAAT, Sequencing, Microarray), Application (Infectious Diseases, Oncology), End User (Hospital, Diagnostic Lab)
8 views • 2 slides
Global Digital Diagnostics Market Research Forecast & Analysis | BIS Research
The Global Digital diagnostics market is estimated to reach $8,319.2 million by 2033 from $1,431.7 million in 2023, growing at a CAGR of 19.24% during the forecast 2023-2033.
9 views • 3 slides
Asia-Pacific Livestock Diagnostics Market
Asia-Pacific Livestock Diagnostics Market by Product (Consumables {Swine Fever, Influenza}, System, Software), Technology (Immunodiagnostics {ELISA, LFA}, PCR), Animal Type (Swine, Bovine, Poultry), End User (POC, Veterinary Hospital) - Forecast to 2030
1 views • 4 slides
Comprehensive Report on Latin America Molecular Diagnostics Market Forecast to 2031 - Meticulous Research
Latin America Molecular Diagnostics Market by Offering (Reagents, Kits, Systems, Software, Services), Test Type (Lab, PoC), Technology (PCR, ISH, INAAT, Sequencing, Microarray), Application (HIV, Influenza, HPV, Oncology), End User - Forecast to 2031\n
0 views • 3 slides
North America Molecular Diagnostics Market Projected to Reach $18.13 Billion by 2030
North America Molecular Diagnostics Market by Product (Reagents & Kits, Systems, Software), Test Type (Lab, PoC), Technology (PCR, ISH, INAAT, Sequencing, Microarray), Application (Infectious Diseases, Oncology, Neurological), End User
0 views • 2 slides
Meticulous Research Releases New Report - Molecular Diagnostics Market Expected to Hit $46.69 Billion by 2030
The molecular diagnostics market comprises advanced products and technologies used by medical professionals for patient management, from diagnosis to treatment, primarily focusing on areas such as infectious disease and cancer.
0 views • 2 slides
Professional BMW Check Engine Light Service Accurate Diagnostics and Efficient Repairs for Reliable Driving
Professional BMW Check Engine Light Service provides precise diagnostics and efficient repairs to ensure your vehicle's optimal performance and reliability. Our expert technicians utilize advanced tools to identify and resolve issues promptly, minimizing downtime and restoring your BMW to peak condi
1 views • 32 slides
Medical Device & Diagnostics Regulatory, Compliance, Post-Market Surveillance
In the heart of Dusseldorf, Germany, the MarketsandMarkets European Medical Device & Diagnostics Regulatory, Compliance, Post-Market Surveillance and Vigilance Conference is set to unfold on the 14th and 15th of October 2024.\n\nRegister Now @ \/\/events.marketsandmarkets.com\/european-medical-devic
1 views • 6 slides
National Free Diagnostics Initiative Overview
The National Free Diagnostics Initiative aims to provide essential diagnostic services free of cost in public health facilities, leveraging existing institutional structures. The initiative covers a range of pathological and radiological tests at different levels of care, with outsourcing for high-c
2 views • 20 slides
Role of Rapid Diagnostic Test for Measles in Global Surveillance
Laboratory-based surveillance is crucial for monitoring and controlling measles outbreaks. The development of new tools like rapid diagnostic tests (RDTs) for measles diagnosis can revolutionize surveillance efforts. Challenges in introducing new diagnostics are discussed, along with the importance
0 views • 30 slides
Helix Diagnostics: State-of-the-Art Clinical Laboratory in Michigan
Helix Diagnostics, founded in 2015 and located in Waterford Township, Michigan, is a cutting-edge clinical laboratory offering services such as therapeutic drug monitoring, blood chemistry testing, pharmacogenomics, and molecular pathogen detection. With over 125 employees, they serve a wide range o
0 views • 11 slides
HIV Rapid Test Procedures and Instructions
This content provides detailed instructions for conducting HIV rapid tests using three different kits: Determine HIV-1/2 Rapid Test, Uni-Gold HIV-1/2 Rapid Test, and Bioline HIV-1/2 Rapid Test. The instructions include steps such as specimen collection, test device preparation, result interpretation
0 views • 5 slides
Rapid Start Learning Collaborative for Infectious Disease Bureau, Boston Public Health Commission
Establishing Rapid Start as a standard of care to increase provider capacity in delivering efficient Rapid ART services, reducing treatment delays, and achieving undetectable viral levels for clients in Suffolk County. The project aims to assess, evaluate, and align efforts for Rapid ART standards,
0 views • 8 slides
Rapid Diagnostics Market on Track to Reach $26.4 Billion by 2029
Meticulous Research\u00ae\u2014a leading global market research company published a research report titled \u201cRapid Diagnostics Market by Product (Kits [OTC, Professional], Readers), Platform (Lateral Flow, Serological, PCR), Application (Blood Gl
0 views • 3 slides
Tuberculosis Diagnostics Market
The Tuberculosis Diagnostics Market is on track to achieve a value of $3.56 billion by 2031, fueled by a 5% CAGR from 2024. Explore the market's significant growth drivers and stay ahead of the curve by understanding future trends in TB diagnostics.\
0 views • 4 slides
GSI Contribution to CR Beam Diagnostics and Future Contracts
Contribution of GSI to CR beam diagnostics includes discussions on diagnostic devices, component status, working questions, and future contracts. Future plans involve the procurement of various devices and components required for beam diagnostics. Known demands for 400 mm diagnostics devices are out
0 views • 16 slides
Rapid Point of Care Training Program - Performing the INSTI HIV Rapid Test
This training module provides a comprehensive guide on conducting rapid HIV testing using the INSTI HIV rapid test. It covers organizing materials, performing blood collection, conducting the test, and interpreting results. The INSTI HIV rapid test is licensed in Canada and approved in Ontario for r
0 views • 12 slides
Advanced Beam Diagnostics and Control Systems in Beam Physics
Cutting-edge detector technologies like KAPTURE and KALYPSO are revolutionizing beam diagnostics with ultra-fast Terahertz detectors and advanced line-camera systems. The POF III and POF IV projects focus on extreme beam control and diagnostics, aiming to probe femto-scale dynamics of relativistic p
0 views • 8 slides
Optimised Live/Dead Fluorescence Spectrometry for Antimicrobial Susceptibility Testing
This study focuses on the optimisation of live/dead fluorescence spectrometry for rapid antimicrobial susceptibility testing. The research uses fluorescent dyes to distinguish between live and dead cells, providing a potential method for quick antimicrobial resistance diagnostics. The experiment inv
0 views • 16 slides
Rapid Influenza Outbreak Detection in Long-Term Care Facilities
The research investigates the effectiveness of rapid diagnostics in detecting influenza outbreaks in long-term care facilities. A non-blinded, randomized controlled trial in Wisconsin LTCFs showed that the intervention led to higher oseltamivir prophylaxis use, decreased ED visits, hospitalizations,
0 views • 6 slides
Resilience, Adaptation, and Reopening: Rapid Antigen Testing Overview
Understanding the importance of rapid antigen testing in the context of resilience, adaptation, and reopening during the ongoing COVID-19 pandemic. Exploring the benefits of rapid screening in detecting asymptomatic carriers, along with the necessity of confirmatory PCR tests for positive results. H
0 views • 28 slides